Taking into account that this study and the studies by Zhang Lei et (29) have potential sample selection errors due to the inclusion of advanced NSCLC patients, and that the PD-1 inhibitors used and the chemotherapy regimens are different. Here, PDCD1 is linked to non-small cell lung carcinoma.